Breast cancer at ASCO 2027
Jun 4–8, 2027 Chicago, IL ~44k attendees Website
18 organizations at ASCO 2027 present work in breast cancer: 13 drug developers, 4 diagnostics, technology and service companies and 1 advocacy group, society, cancer center, publisher or agency. 18 of them have their own page in this guide. As of Oct 8, 2026.
Showing 1–18 of 18 organizations
| Organization | ASCO 2027 Attendance |
|---|---|
Agendia Irvine, CA | |
Breast cancer genomics company whose MammaPrint and BluePrint tests gauge recurrence risk and tumor subtype to guide early-stage treatment. | Booth Exhibiting at Booth 27147 |
AstraZeneca Cambridge, UK | |
Global drugmaker with cancer medicines across lung, breast, blood and other cancers, including targeted therapies, immunotherapy and ADCs. | Booth Exhibiting at Booth 19029 |
Celcuity Minneapolis, MN | |
Clinical-stage biotech developing gedatolisib, a PI3K/mTOR pathway inhibitor in Phase 3 for HR-positive, HER2-negative advanced breast cancer. | Booth Exhibiting at Booth 15149, 16151 |
Daiichi Sankyo Tokyo, Japan | |
Japanese drugmaker known for antibody-drug conjugates, including trastuzumab deruxtecan (Enhertu) and datopotamab deruxtecan, for breast, lung and gastric cancers. | Booth Exhibiting at Booth 27073 |
Delphi Diagnostics Houston, TX | |
Texas company commercializing the Endocrine Activity Index, a test of endocrine activity in stage II–III HR-positive, HER2-negative breast cancer. | Booth Exhibiting at Booth 29069 |
Eisai Tokyo, Japan | |
Japanese drugmaker whose cancer medicines include lenvatinib, used in thyroid, liver, kidney and endometrial cancers, and eribulin for breast cancer. | Booth Exhibiting at Booth 19093 |
Eli Lilly Indianapolis, IN | |
Global drugmaker whose cancer medicines include abemaciclib for breast cancer, selpercatinib for RET-driven cancers and pirtobrutinib for blood cancers. | Booth Exhibiting at Booth 19079 |
Exact Sciences Madison, WI | |
Cancer screening and diagnostics company, now part of Abbott, known for the Cologuard colon cancer screening test and Oncotype DX breast cancer test. | Booth Exhibiting at Booth 22094 |
Genentech South San Francisco, CA | |
Roche company and biotechnology drugmaker with cancer medicines for breast, lung and blood cancers, including atezolizumab and bispecific antibodies. | Booth Exhibiting at Booth 19001 |
Gilead and Kite Foster City, CA | |
Gilead and its cell therapy company Kite, offering the ADC sacituzumab govitecan for breast cancer and CAR-T therapies for lymphoma and leukemia. | Booth Exhibiting at Booth 23001 |
Menarini Stemline New York, NY | |
Menarini Group oncology company marketing elacestrant for ESR1-mutated breast cancer and tagraxofusp for a rare blood cancer. | Booth Exhibiting at Booth 10077 |
Myriad Genetics Salt Lake City, UT | |
Genetic testing company offering hereditary cancer risk tests, tumor tests such as homologous recombination deficiency, and pharmacogenomics. | Booth Exhibiting at Booth 13068 |
Novartis Basel, Switzerland | |
Global drugmaker whose cancer medicines include ribociclib for breast cancer, Pluvicto radioligand therapy for prostate cancer and blood cancer treatments. | Booth Exhibiting at Booth 15059, 15078 |
Olema Oncology San Francisco, CA | |
Clinical-stage biotech developing endocrine therapies for metastatic breast cancer, led by the complete estrogen receptor antagonist palazestrant. | Booth Exhibiting at Booth 10106 |
Pfizer New York, NY | |
Global drugmaker whose oncology portfolio spans ADCs from Seagen, small molecules, bispecifics and immunotherapies for breast, prostate, bladder, lung and blood cancers. | Booth Exhibiting at Booth 30071 · Pfizer Oncology |
Puma Biotechnology Los Angeles, CA | |
Oncology company marketing neratinib (Nerlynx) for HER2-positive breast cancer and testing the aurora kinase A inhibitor alisertib in small cell lung and breast cancers. | Booth Exhibiting at Booth 15143 |
San Antonio Breast Cancer Symposium San Antonio, TX | |
Annual scientific meeting in San Antonio covering breast cancer biology, prevention, diagnosis and treatment for physicians and researchers. | Booth Exhibiting at Booth 10030 |
TerSera Therapeutics Deerfield, IL | |
Specialty company acquiring and marketing oncology and rare disease medicines, including goserelin (Zoladex) in the US. | Booth Exhibiting at Booth 29165 |
Instantly find 20 buyers in breast cancer
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse ASCO 2027 by
Organization type
Focus
- Clinical trials 58
- Biomarkers and genomics 44
- AI and data 38
- Blood cancers 36
- Lung cancer 28
- Genitourinary cancers 24
- Gastrointestinal cancers 21
- Breast cancer 18
- Immunotherapy 17
- Imaging and radiation 17
- Patient support and survivorship 14
- Antibody-drug conjugates 9
- Cell and gene therapy 8
- Melanoma and skin cancers 7
- Gynecologic cancers 6
Exhibit hall
Everyone
Not affiliated with the American Society of Clinical Oncology. Organization details are derived from ASCO’s published exhibitor list and each exhibitor’s own profile and website. Submit a correction